196 related articles for article (PubMed ID: 32060857)
21. Hydroxysafflor Yellow A Alleviates Ischemic Stroke in Rats via HIF-1[Formula: see text], BNIP3, and Notch1-Mediated Inhibition of Autophagy.
Zhang Y; Liu Y; Cui Q; Fu Z; Yu H; Liu A; Liu J; Qin X; Ge S; Zhang G
Am J Chin Med; 2022; 50(3):799-815. PubMed ID: 35300568
[TBL] [Abstract][Full Text] [Related]
22. SOCS3 Silencing Promotes Activation of Vocal Fold Fibroblasts via JAK2/STAT3 Signaling Pathway.
Li X; Hu R; Wang H; Xu W
Inflammation; 2023 Aug; 46(4):1318-1331. PubMed ID: 37154979
[TBL] [Abstract][Full Text] [Related]
23. Hydroxysafflor Yellow A Reprograms TLR9 Signalling Pathway in Ischaemic Cortex after Cerebral Ischaemia and Reperfusion.
Gong Z; Pan J; Li X; Wang H; He L; Peng Y
CNS Neurol Disord Drug Targets; 2018; 17(5):370-382. PubMed ID: 29732997
[TBL] [Abstract][Full Text] [Related]
24. [Inhibitory action of hydroxysafflor yellow A on inflammatory signal transduction pathway related factors in rats with cerebral cortex ischemia].
Chen TT; Du YJ; Liu XL; Zhu HB
Yao Xue Xue Bao; 2008 Jun; 43(6):570-5. PubMed ID: 18822957
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of JAK2/STAT3/SOCS3 signaling attenuates atherosclerosis in rabbit.
Yang X; Jia J; Yu Z; Duanmu Z; He H; Chen S; Qu C
BMC Cardiovasc Disord; 2020 Mar; 20(1):133. PubMed ID: 32169038
[TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetic-pharmacodynamic modeling analysis for hydroxysafflor yellow A-calycosin in compatibility in normal and cerebral ischemic rats: A comparative study.
Chen Q; Wan J; Zhang Y; He Y; Bao Y; Yu L; Yang J
Biomed Pharmacother; 2022 Jun; 150():112950. PubMed ID: 35427818
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of Connexin43 hemichannels with Gap19 protects cerebral ischemia/reperfusion injury via the JAK2/STAT3 pathway in mice.
Chen B; Yang L; Chen J; Chen Y; Zhang L; Wang L; Li X; Li Y; Yu H
Brain Res Bull; 2019 Mar; 146():124-135. PubMed ID: 30593877
[TBL] [Abstract][Full Text] [Related]
28. Salvianolic acids enhance cerebral angiogenesis and neurological recovery by activating JAK2/STAT3 signaling pathway after ischemic stroke in mice.
Li Y; Zhang X; Cui L; Chen R; Zhang Y; Zhang C; Zhu X; He T; Shen Z; Dong L; Zhao J; Wen Y; Zheng X; Li P
J Neurochem; 2017 Oct; 143(1):87-99. PubMed ID: 28771727
[TBL] [Abstract][Full Text] [Related]
29. Hydroxysafflor Yellow A Attenuates Neuron Damage by Suppressing the Lipopolysaccharide-Induced TLR4 Pathway in Activated Microglial Cells.
Lv Y; Qian Y; Ou-Yang A; Fu L
Cell Mol Neurobiol; 2016 Nov; 36(8):1241-1256. PubMed ID: 26754542
[TBL] [Abstract][Full Text] [Related]
30. The potential mechanism for Hydroxysafflor yellow A attenuating blood-brain barrier dysfunction via tight junction signaling pathways excavated by an integrated serial affinity chromatography and shotgun proteomics analysis approach.
Lv Y; Fu L
Neurochem Int; 2018 Jan; 112():38-48. PubMed ID: 29107696
[TBL] [Abstract][Full Text] [Related]
31. Protective effect of Hydroxysafflor Yellow A on cerebral ischemia reperfusion-injury by regulating GSK3β-mediated pathways.
Yang X; Chen L; Li Y; Gao F; Yan Z; Zhang P; Wu J; Wang H; Sun B
Neurosci Lett; 2020 Sep; 736():135258. PubMed ID: 32693014
[TBL] [Abstract][Full Text] [Related]
32. Hydroxysafflor Yellow A mitigated myocardial ischemia/reperfusion injury by inhibiting the activation of the JAK2/STAT1 pathway.
Zhou D; Ding T; Ni B; Jing Y; Liu S
Int J Mol Med; 2019 Aug; 44(2):405-416. PubMed ID: 31173173
[TBL] [Abstract][Full Text] [Related]
33. Nrf2 induces lipocyte phenotype via a SOCS3-dependent negative feedback loop on JAK2/STAT3 signaling in hepatic stellate cells.
Lu C; Xu W; Shao J; Zhang F; Chen A; Zheng S
Int Immunopharmacol; 2017 Aug; 49():203-211. PubMed ID: 28601022
[TBL] [Abstract][Full Text] [Related]
34. Nephrotoxicity instead of immunotoxicity of OTA is induced through DNMT1-dependent activation of JAK2/STAT3 signaling pathway by targeting SOCS3.
Gan F; Zhou X; Zhou Y; Hou L; Chen X; Pan C; Huang K
Arch Toxicol; 2019 Apr; 93(4):1067-1082. PubMed ID: 30923867
[TBL] [Abstract][Full Text] [Related]
35. Hydroxysafflor yellow A protects neuron against hypoxia injury and suppresses inflammatory responses following focal ischemia reperfusion in rats.
Ye SY; Gao WY
Arch Pharm Res; 2008 Aug; 31(8):1010-5. PubMed ID: 18787790
[TBL] [Abstract][Full Text] [Related]
36. m
Wu R; Liu Y; Zhao Y; Bi Z; Yao Y; Liu Q; Wang F; Wang Y; Wang X
Cell Death Dis; 2019 Feb; 10(3):171. PubMed ID: 30787270
[TBL] [Abstract][Full Text] [Related]
37. Hydroxysafflor Yellow A Shows Protection against PPAR
Sun L; Xu YW; Han J; Xiao C; Cao SS; Liang H; Cheng Y
Oxid Med Cell Longev; 2018; 2018():9101740. PubMed ID: 30410641
[TBL] [Abstract][Full Text] [Related]
38. Solid lipid nanoparticles as carriers for oral delivery of hydroxysafflor yellow A.
Zhao B; Gu S; Du Y; Shen M; Liu X; Shen Y
Int J Pharm; 2018 Jan; 535(1-2):164-171. PubMed ID: 29107614
[TBL] [Abstract][Full Text] [Related]
39. Hydroxysafflor yellow A cardioprotection in ischemia-reperfusion (I/R) injury mainly via Akt/hexokinase II independent of ERK/GSK-3β pathway.
Min J; Wei C
Biomed Pharmacother; 2017 Mar; 87():419-426. PubMed ID: 28068632
[TBL] [Abstract][Full Text] [Related]
40. Effects of hydroxysafflor yellow A on the activity and mRNA expression of four CYP isozymes in rats.
Xu RA; Xu ZS; Ge RS
J Ethnopharmacol; 2014 Feb; 151(3):1141-1146. PubMed ID: 24373810
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
